Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-18

FDA Approved: PULMICORT RESPULES — Supplemental Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

The FDA approved a supplemental application for Pulmicort Respules (budesonide) from AstraZeneca Pharmaceuticals LP, signaling an approved change to the existin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pulmicort Respules (budesonide)

Snippet

SUPPL AP for PULMICORT RESPULES (BUDESONIDE)